The start-up Kastafiore has developed an innovative solution for collecting real-world research data, which was used in the Mentalo study, a project recognized by the President of the French Republic.
The Grande Exposition du Fabriqué en France returned for the third time. A vernissage was held in the presence of the President of the Republic at the Elysée Palace.
Start-up Orixha, a spin-off from Erganeo specialising in fluid ventilation technology, has raised €4 million from the European Innovation Council Fund (EIC) and the French Tech Seed fund managed by Bpifrance.
Supported by Erganeo since 2016, METHYS Dx has been in the spotlight through several news articles.
On Tuesday July 4, 2023, the French Ministry of Higher Education, Research and Innovation, in partnership with Bpifrance, organized the awards ceremony for the winners of the 2023 innovation competitions.
On 2 June 2023, Summit Pharmaceuticals International, a biopharmaceutical company, and start-up EVerZom signed an exclusive distribution agreement in Japan.
The start-up, IPCure, and Erganeo have signed a licence agreement for the exclusive exploitation of a new type of compounds for the treatment of certain diseases with an inflammatory component.
ARCHOS announces that its Medical Devices Venture subsidiaries, Dextrain and Poladerme, have been awarded the BPI Deep tech label and the French Tech Emergence grant (BFTE).
Orixha, an Erganeo start-up specialising in liquid ventilation technology, has won the Innovation 2022 Prize at the MEDI'NOV trade fair pitch session.
For the thirteenth consecutive year, Challenges has published its selection of "100 start-ups to invest in".
Orixha announces a €2 million financing round from Angels Santé, Erganeo and its industrial partners, InfiPlast, OEM Development and Activation.
EverZom announces that it has obtained €2.5 million in European funding to accelerate the bioproduction of exosomes for the regenerative medicine of tomorrow.
AbilyCare joined Erganeo's Start-up Factory program to bring to market a new version of the device that meets the additional expectations expressed by healthcare professionals.
The French company Jamespot, has just purchased the start-up Open Agora, specialized in collecting opinions on the Slack and Microsoft Teams platforms.
On 17 April, Brainvectis, a start-up supported by Erganeo specialising in neurodegenerative disease treatments, was acquired by American company Asklepios BioPharmaceutical (AskBio).
From the moment it launched, through Erganeo, Kurma Partners, Idinvest Partners and Domain Therapeutics, the start-up succeeded in raising €6.3m.
468 candidates submitted their applications to the panel for the 21st edition of the award, and 75 winners were selected, including four start-ups backed by Erganeo.
Neurallys announced that it has raised €750,000 in funds from the Doliam group and HACFutur to be plowed into accelerating development for its connected implant designed for use in thousands of hydrocephalus patients.
